AU538005B2 - Piperazine derivatives - Google Patents

Piperazine derivatives

Info

Publication number
AU538005B2
AU538005B2 AU61719/80A AU6171980A AU538005B2 AU 538005 B2 AU538005 B2 AU 538005B2 AU 61719/80 A AU61719/80 A AU 61719/80A AU 6171980 A AU6171980 A AU 6171980A AU 538005 B2 AU538005 B2 AU 538005B2
Authority
AU
Australia
Prior art keywords
piperazine
alkoxy
hydrogen
benzyl
halogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU61719/80A
Other languages
English (en)
Other versions
AU6171980A (en
Inventor
Dezsoe Peteri
Arthur Scherm
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Friedrich Merz GmbH
Original Assignee
Merz and Co GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19792934450 external-priority patent/DE2934450C2/de
Priority claimed from DE2934488A external-priority patent/DE2934488C2/de
Application filed by Merz and Co GmbH and Co KG filed Critical Merz and Co GmbH and Co KG
Publication of AU6171980A publication Critical patent/AU6171980A/en
Application granted granted Critical
Publication of AU538005B2 publication Critical patent/AU538005B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/66—Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU61719/80A 1979-08-25 1980-08-25 Piperazine derivatives Ceased AU538005B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE19792934450 DE2934450C2 (de) 1979-08-25 1979-08-25 N-(Trimethoxybenzyl)-piperazinderivate und deren Salze, Verfahren zu deren Herstellung und Arzneimittel
DE29344885 1979-08-25
DE29344501 1979-08-25
DE2934488A DE2934488C2 (de) 1979-08-25 1979-08-25 N-(Trimethoxybenzyl)-N'-(einfachsubstituierte-phenyl)-piperazine, deren Salze, Verfahren zu deren Herstellung und Arzneimittel

Publications (2)

Publication Number Publication Date
AU6171980A AU6171980A (en) 1981-03-05
AU538005B2 true AU538005B2 (en) 1984-07-26

Family

ID=25780725

Family Applications (1)

Application Number Title Priority Date Filing Date
AU61719/80A Ceased AU538005B2 (en) 1979-08-25 1980-08-25 Piperazine derivatives

Country Status (18)

Country Link
US (2) US4370329A (enExample)
AT (1) AT375075B (enExample)
AU (1) AU538005B2 (enExample)
CA (1) CA1153377A (enExample)
CH (1) CH643549A5 (enExample)
DK (1) DK363280A (enExample)
ES (1) ES8104264A1 (enExample)
FR (1) FR2463768A1 (enExample)
GB (1) GB2057441B (enExample)
GR (1) GR69917B (enExample)
HU (1) HU182180B (enExample)
IL (1) IL60891A (enExample)
MX (1) MX6163E (enExample)
NL (1) NL8004783A (enExample)
PL (1) PL125663B1 (enExample)
SE (1) SE8005943L (enExample)
SG (1) SG3385G (enExample)
YU (1) YU211480A (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4713382A (en) * 1985-05-30 1987-12-15 Syntex (U.S.A.) Inc. N-phenyl-4-phenyl-1-piperazinecarboxamidines and related compounds as antiarrhythmic agents
IL85700A0 (en) * 1987-03-24 1988-08-31 Takeda Chemical Industries Ltd 1,4-disubstituted piperazine compounds,their production and use
DE3715763A1 (de) * 1987-05-12 1988-11-24 Hoechst Ag Diarylalkyl-substituierte alkylamine, verfahren zu ihrer herstellung, ihre verwendung sowie sie enthaltende arzneimittel
US5346653A (en) * 1991-02-18 1994-09-13 Matsushita Electric Industrial Co., Ltd. Non-linear optical material, method of manufacturing the same and optical wavelength converter
US5965560A (en) * 1996-04-30 1999-10-12 Warner-Lambert Company Substituted piperazines and piperidines as central nervous system agents
HUP9601331A3 (en) * 1996-05-17 2000-06-28 Egyt Gyogyszervegyeszeti Gyar Piperazine- and homopiperazine-derivatives, process for producing them and pharmaceutical compositions containing them
US5859246A (en) * 1997-01-30 1999-01-12 Neurogen Corporation 1-phenyl-4-benzylpiperazines: dopamine receptor subtype specific ligands
WO2002004433A2 (en) 2000-07-06 2002-01-17 Neurogen Corporation Melanin concentrating hormone receptor ligands
BR0209932A (pt) * 2001-05-22 2004-10-13 Neurogen Corp Composto ou sal farmaceuticamente aceitável do mesmo, composição farmacêutica, preparação farmacêutica embalada, métodos para modular ligação de mch a um receptor de mch e de mvc, para alterar a atividade de transdução de sinal de um receptor de mch em uma célula, para tratar uma doença ou distúrbio associado com a ativação de receptor de mch patogênico obesidade e para determinar a presença ou ausência de receptor de mch em uma amostra, e, uso de um composto
RU2260431C2 (ru) * 2003-12-15 2005-09-20 Закрытое акционерное общество "Фармацевтическое предприятие "Оболенское" Лекарственная форма, обладающая антиангинальным действием, и способ ее изготовления
WO2005110982A2 (en) * 2004-04-07 2005-11-24 Neurogen Corporation Substituted 1-benzyl-4-substituted piperazine analogues
WO2005110989A1 (en) * 2004-04-07 2005-11-24 Neurogen Corporation Substituted 1-heteroaryl-4-substituted piperazine and piperidine analogues
TW200609219A (en) * 2004-06-17 2006-03-16 Neurogen Corp Aryl-substituted piperazine derivatives
RU2281772C1 (ru) * 2005-02-14 2006-08-20 Закрытое акционерное общество "Фармацевтическое предприятие "Оболенское" Лекарственная форма, обладающая антиангинальным действием, и способ ее изготовления

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB868353A (en) 1959-12-01 1961-05-17 Soc Ind Fab Antibiotiques Sifa Phenyl piperazine derivatives for therapeutic use and processes for the production of such derivatives
FR1275308A (fr) * 1960-11-30 1961-11-03 Soc Ind Fab Antibiotiques Sifa Nouveaux dérivés de la phényl pipérazine, et leur préparation
GB939822A (en) * 1961-03-29 1963-10-16 Soc Ind Fab Antibiotiques Sifa Piperazine compounds
US4100285A (en) 1976-04-09 1978-07-11 Nippon Shinyaku Co., Ltd. N-substituted trialkoxybenzyl piperazine derivatives

Also Published As

Publication number Publication date
HU182180B (en) 1983-12-28
SE8005943L (sv) 1981-02-26
PL125663B1 (en) 1983-06-30
FR2463768A1 (fr) 1981-02-27
GB2057441B (en) 1983-05-25
US4370329A (en) 1983-01-25
AU6171980A (en) 1981-03-05
US4370330A (en) 1983-01-25
CH643549A5 (de) 1984-06-15
PL226396A1 (enExample) 1981-10-30
IL60891A (en) 1984-03-30
CA1153377A (en) 1983-09-06
FR2463768B1 (enExample) 1983-11-25
MX6163E (es) 1984-11-29
DK363280A (da) 1981-02-26
ATA423080A (de) 1983-11-15
IL60891A0 (en) 1980-10-26
NL8004783A (nl) 1981-02-27
ES494426A0 (es) 1981-04-01
ES8104264A1 (es) 1981-04-01
SG3385G (en) 1985-06-14
YU211480A (en) 1983-06-30
GB2057441A (en) 1981-04-01
GR69917B (enExample) 1982-07-21
AT375075B (de) 1984-06-25

Similar Documents

Publication Publication Date Title
AU533566B2 (en) Aminoalkylbenzene derivatives
AU538841B2 (en) Quindine derivatives
AU542537B2 (en) Nor-tropane derivatives
AU516325B2 (en) Spiro-imidazolidinedione derivatives
AU547149B2 (en) 3-aminopropoxy - indole derivatives
AU529742B2 (en) Alkyl-ketohexopyranoside derivatives
AU547872B2 (en) Tripeptidic derivatives
AU534806B2 (en) 3-vinyl-cephalosporin derivatives
AU538138B2 (en) Methylene-cycloamine derivatives
AU6171980A (en) Piperazine derivatives
AU533797B2 (en) Thioethylamide derivatives
AU520245B2 (en) Glycerylphosphoryl derivatives
AU526214B2 (en) Pteridin derivatives
AU538139B2 (en) 3-methyleneazetidine derivatives
AU5649780A (en) Biphosphite derivatives
AU530761B2 (en) Halo-vincamone derivatives
AU533484B2 (en) Tetrahydrochinoline derivatives
AU538087B2 (en) Halophenyl-pyridyl - allylamine derivatives
GB2053897B (en) Piperazine derivatives
AU538028B2 (en) 1-oxadethiacephalosporin derivatives
AU6119980A (en) Benzoxocin derivatives
AU534308B2 (en) 15-hydroxyimino-e-homo-eburnane derivatives
AU518068B2 (en) 15-sulfonamidoprostaglandin derivatives
AU543045B2 (en) 1-phenethylimidazole derivatives
AU535462B2 (en) Amino-isoquinoline derivatives